genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
GEN Edge
‘One-Stop Shop’ for Developing Cell and Gene Therapies
GEN Edge
At Suburban N.Y. Campus, BioMed Realty Thinks Small
News
Coronavirus
Coronavirus Patients May Carry Virus for a Week after Symptoms Have…
News
German Scientists Identify and Characterize a Novel Plastic-Degrading Bacterium
Coronavirus
Sanofi Expands COVID-19 Pipeline with Translate Bio Partnership
Coronavirus
Mining the SARS-CoV-2 Genome for Answers
News
Microbiome May Identify Female Precancer Risk from HPV
Insights
All
Trends for 2020
Coronavirus
Moderna’s SARS-CoV-2 Vaccine’s Fast Track to Clinical Trials
Bioprocessing
Personalized Medicine Prompts a ‘Rethink’ among Bioprocessors
Artificial Intelligence
Artificial Intelligence and Outsourcing Impact Bioprocessing Operations
Bioprocessing
This Does Not Compute
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
Ovarian Cancer Cells’ Dependence on Fat Opens up Potential New Treatment
Coronavirus
Sanofi Expands COVID-19 Pipeline with Translate Bio Partnership
Coronavirus
Mining the SARS-CoV-2 Genome for Answers
News
Microbiome May Identify Female Precancer Risk from HPV
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
GENcast: Navigating Your Lab through a Digital Transformation
Upcoming Webinars
Cas-CLOVER: The Clean Alternative to CRISPR-Cas9
Keynote Webinars
Settling the Score with Genetic Diseases
GENcast
Helping Biosimilars Emerge into Global Markets Takes a Practiced Hand
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Cellular Therapeutics
Cellular Therapeutics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cellular Therapeutics
From J.P. Morgan: Cell, Gene Therapy to Drive Biopharma M&A in 2020
Cellular Therapeutics
Vertex Expanding into Diabetes Cell Therapy with Plans to Acquire Semma
Cellular Therapeutics
BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing
Cellular Therapeutics
Cancer-Killing T Cells Subdued, Kept “Stemmy,” by Potassium
Cellular Therapeutics
Israel’s Sheba Medical Center to Manufacture Cell Therapies Using Lonza’s Cocoon Platform
Cellular Therapeutics
Cancer Spread and Blood Clots May Be Halted by Platelet Decoys
Cellular Therapeutics
Capricor Axes About Half Its Workforce, Resumes Dosing in Trial of...
Cellular Therapeutics
Cell Therapy Manufacturing: The Supply Chain Challenge
Cellular Therapeutics
Conjoined Cells Form a Potent Immunotherapy Combo
Cellular Therapeutics
GE Healthcare, Swedish Government Open an Innovation Center in Uppsala
Cellular Therapeutics
Astellas Expands Its Eye Disorder Pipeline with Quethera Purchase
Cellular Therapeutics
Torque Unveils Manufacturing Platform for Its “Deep Primed” T-Cell Cancer Therapies
Cellular Therapeutics
Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition
Cellular Therapeutics
Teratoma-Derived Stem Cells Rebuild Muscle in Model of Muscular Dystrophy
Cellular Therapeutics
CRISPR “One Shot” Cell Therapy for Hemophilia Developed
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]](https://www.genengnews.com/wp-content/uploads/2018/08/ENTrIA_recognition_EN_without_entria1024x9291472362223-324x160.png "Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition")
